Anavex Life Sciences's market cap is currently $740.06M. The company's EPS TTM is $-0.552; its P/E ratio is ―; Anavex Life Sciences is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ 0.00	$ -55.76M	$ -54.40M	$ -41.92M	$ -30.76M
EBITDA	$ 0.00	$ -55.76M	$ -50.94M	$ 0.00	$ 0.00
Net Income	$ -43.00M	$ -47.51M	$ -47.98M	$ -37.91M	$ -26.28M
Balance Sheet
Cash & Short-Term Investments	$ 132.19M	$ 151.02M	$ 149.16M	$ 152.11M	$ 29.25M
Total Assets	$ 135.57M	$ 154.39M	$ 152.70M	$ 161.62M	$ 34.54M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -132.19M	$ -151.02M	$ -149.16M	$ -152.11M	$ -29.25M
Total Liabilities	$ 15.30M	$ 12.53M	$ 10.21M	$ 10.80M	$ 7.31M
Stockholders' Equity	$ 120.26M	$ 141.85M	$ 142.49M	$ 150.82M	$ 27.24M
Cash Flow
Free Cash Flow	$ -30.81M	$ -27.79M	$ -24.24M	$ -30.38M	$ -21.29M
Operating Cash Flow	$ -30.81M	$ -27.79M	$ -24.24M	$ -30.38M	$ -21.29M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 11.97M	$ 29.65M	$ 21.29M	$ 153.24M	$ 28.35M

Currency in USD

Anavex Life Sciences Earnings and Revenue History

Income Statement >

Anavex Life Sciences Debt to Assets

Balance Sheet >

Anavex Life Sciences Cash Flow

Cash Flow >

Anavex Life Sciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing